Medicines Co., Alnylam Pharma Initiate Phase III Clinical Trial Of Inclisiran

The Medicines Co. (MDCO) and Alnylam Pharmaceuticals, Inc. (ALNY) said they have initiated a Phase III clinical program for inclisiran.

from RTT - Biotech http://ift.tt/2zhYQtf
via IFTTT